| 31-Dec-12 | 31-Dec-11 | 31-Dec-10 | 31-Dec-09 | 31-Dec-08 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||
| Canada | 1,614.00 | 17% | 1,483.00 | 16% | n/a | n/a | n/a | n/a | n/a | n/a |
| Emerging Markets | 1,237.00 | 13% | 1,103.00 | 12% | 19.00 | n/a | 833.00 | 11% | 738.00 | 10% |
| International | n/a | n/a | n/a | n/a | 3,536.00 | 42% | 3,249.00 | 42% | 2,998.00 | 41% |
| Scandinavia | 1,791.00 | 19% | 1,824.00 | 20% | n/a | n/a | n/a | n/a | n/a | n/a |
| UK | 3,689.00 | 39% | 3,701.00 | 41% | 2,925.00 | 35% | 2,632.00 | 34% | 2,711.00 | 37% |
| Unanalysed | 1,066.00 | 11% | 1,020.00 | 11% | 1,968.00 | 23% | 1,030.00 | 13% | 826.00 | 11% |
| Total | 9,397.00 | 100% | 9,131.00 | 100% | 8,448.00 | 100% | 7,744.00 | 100% | 7,273.00 | 100% |
| Profit Before Tax | ||||||||||
| Canada | 152.00 | 20% | 182.00 | 22% | n/a | n/a | n/a | n/a | n/a | n/a |
| Emerging Markets | 46.00 | 6% | 12.00 | 1% | 19.00 | 3% | 24.00 | 3% | 34.00 | 4% |
| International | n/a | n/a | n/a | n/a | 557.00 | 77% | 516.00 | 60% | 493.00 | 52% |
| Scandinavia | 322.00 | 42% | 379.00 | 46% | n/a | n/a | n/a | n/a | n/a | n/a |
| UK | 244.00 | 32% | 251.00 | 30% | 149.00 | 21% | 314.00 | 37% | 417.00 | 44% |
| Unanalysed | (285.00) | n/a | (211.00) | n/a | (251.00) | n/a | (300.00) | n/a | (185.00) | n/a |
| Total | 479.00 | 100% | 613.00 | 100% | 474.00 | 100% | 554.00 | 100% | 759.00 | 100% |
| 31-Dec-12 | 31-Dec-11 | 31-Dec-10 | 31-Dec-09 | 31-Dec-08 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||
| Personal & Commercial general insurance | 9,397.00 | 100% | 9,131.00 | 100% | 8,448.00 | 100% | n/a | n/a | n/a | n/a |
| Total | 9,397.00 | 100% | 9,131.00 | 100% | 8,448.00 | 100% | 7,744.00 | n/a | 7,273.00 | n/a |
| Profit Before Tax | ||||||||||
| Personal & Commercial general insurance | 479.00 | 100% | 613.00 | 100% | 474.00 | 100% | n/a | n/a | n/a | n/a |
| Total | 479.00 | 100% | 613.00 | 100% | 474.00 | 100% | 554.00 | n/a | 759.00 | n/a |
You are here: research